Shanghai Doning Biology
Shield the company
Unmask

Biotechnology · 500-999 persons · D wheel and above

Shanghai Doning Biotechnology Co., Ltd. (hereinafter referred to as "Doning Biotechnology") is a one-stop biological process solution provider, committed to providing comprehensive solutions for biopharmaceutical products from R&D to commercial production, including reagents and consumables, equipment and services. The company operates two business lines of biological process solutions, laboratory products and services, and helps partners to achieve efficient, stable, quality and cost controllable drug development and production processes through the one-stop biological process system. Doning Biological has more than 890 employees, 290 patents and patent applications, and 12 production bases (with a total floor area of about 82000 m2). The company will provide high-quality and cost-effective products and services for pharmaceutical companies, CRO/CDMO, and research institutions based on a technically specialized team, strong R&D and manufacturing capabilities, and an international layout. At present, the company can provide more than 240 products and 140 services, with applications covering antibody, cell and gene therapy, vaccine, etc. Doning Biological has a culture medium development and production platform with independent intellectual property rights. The R&D team has developed a series of serum free animal cell culture media for the biopharmaceutical industry based on cell metabolism and physiological research and guided by the needs of the biotechnology industry. At the moment when China's biopharmaceutical industry is booming, the company focuses on improving the research and production efficiency of biopharmaceuticals, continuously improving the efficiency of cell culture, and continuously enabling the research and development and industrialization of biopharmaceuticals; At the same time, in the principle of helping customers optimize cell culture technology and win-win cooperation, we can customize high-quality and personalized animal cell culture media according to customer needs; Research, development and production of disposable biopharmaceutical process equipment and consumables for the wide application of disposable products, bioreactors, filters, etc. in biopharmaceuticals; Provide professional GMP compliance testing and verification services to enterprises and institutions such as new drug research and development, biotechnology development, medical care, etc. with the inspection contents of biosafety testing, instrument and equipment verification, on-site services, etc. Doning Biology always aims at "providing one-stop service for customers" and strives to become a comprehensive service provider providing complete solutions for the biopharmaceutical field. https://www.duoningbio.com/
...
View All Stow

Qualification

Business Information
Data source:

Full name of enterprise

Shanghai Duoning Biotechnology Co., Ltd

Date of establishment

June 7, 2005

registered capital

RMB 400.6763 million

Legal representative

Wang Meng

Registered address

Room 110, Building 20, No. 29, Lane 1698, Wangyuan Road, Fengxian District, Shanghai

Unified credit code

91310104776270040D

Industry

Biotechnology

Location

Shanghai

registration authority

Shanghai Municipal Market Supervision Administration

Business Term

2005-06-07

Enterprise type

Limited liability company (invested by Hong Kong, Macao and Taiwan, unlisted)

Business status

subsist

Business scope

General items: technical services, technical development, technical consultation, technical exchange, technology transfer, technology promotion (except for human stem cells, gene diagnosis and treatment technology development and application); Wholesale of chemical raw materials and chemical products (excluding hazardous chemicals, monitored chemicals, fireworks, civil explosives, precursor chemicals), special chemical equipment, instruments, packaging materials, laboratory equipment, glassware; Engaging in the production of biological agents (it is prohibited to invest in the production of Chinese patent medicines, precious fine varieties, fine genes, genetically modified varieties and related reproductive materials); Sales of chemical products (excluding licensed chemical products); Sales of special chemical products (excluding hazardous chemicals); Sales of machinery and equipment; Instrument sales; Sales of packaging materials and products; Medical research and experimental development (except the development and application of human stem cells, gene diagnosis and treatment technology); Sales of glassware; Sales of pharmaceutical special equipment; Retail of computer software, hardware and auxiliary equipment; Own equipment leasing; Instrument repair; Manufacturing of special pharmaceutical equipment; Sales of industrial control computers and systems; Research and development of fermentation process optimization technology; R&D of biochemical product technology; Manufacturing of new membrane materials; Research and development of bio based materials technology; Manufacturing and sales of medical packaging materials; Gas, liquid separation and purification equipment manufacturing sales. (In addition to the items that need to be approved according to law, they can independently carry out business activities according to law with the business license) Permitted items: import and export of goods; Technology import and export; Inspection and testing services. (Projects that need to be approved according to law can only be operated after being approved by relevant departments. Specific business projects shall be subject to the approval documents or permits of relevant departments.)

Log in to view business information
Login/Registration
Financing
02 two thousand and twenty-two
Strategic financing undisclosed
Investment institution: Unpublished
eleven two thousand and twenty-one
C wheel undisclosed
Investment institution: Defu Capital / Huitianfu / Sequoia China / Chentao Capital
twelve two thousand and twenty
Wheel B RMB 100 million
Investment institution: Sequoia China
04 two thousand and nineteen
A+wheel 100 million RMB
Investment institution: Huiqiao Capital
09 two thousand and eighteen
Wheel A undisclosed
Investment institution: Hongjia Assets
07 two thousand and eighteen
Seed wheel undisclosed
Investment institution: Unpublished
Financing timeline